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The proportion of elderly people in the population is steadily increasing, and the inevitable
consequence is that this subpopulation is more frequently represented in common med-
ical procedures and surgeries. Understanding the circulatory changes that accompany the
aging process is therefore becoming increasingly timely and relevant. In this short review,
we discuss aspects of vascular control in aging that are particularly relevant in the main-
tenance of intraoperative hemodynamic stability. We subsequently review the effects of
certain notable anesthetic agents with respect to the aging vasculature.
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INTRODUCTION
The percentage of the population over the age of 65 is steadily
increasing and is expected to continue in the foreseeable future
(United-Nations, 2002),with people over the age of 80 now among
the fastest growing subset of the population (Jarad, 2011). Cur-
rently, cardiovascular diseases (CVDs) are themost common cause
of death among elderly patients in the Western world, accounting
for more than 40% of all mortalities among people aged 65–74,
and 60% of people 85 years and older (Ungvari et al., 2010). More-
over, almost 70% of the population over the age of 70 has some
degree of hypertension, which reﬂects the fact that blood pressure
increases with age (Pedelty and Gorelick, 2008; Wills et al., 2011).
Despite the increased risk of CVD associated with aging,
evidence indicates that health among the elderly population is
improving, as illustrated by falling rates of ischemic heart dis-
ease, heart failure, and cerebrovascular disease among people
over the age of 80 (National Heart, Lung and Blood Institute,
2006; Perls, 2009). The inevitable consequence of increasing life
expectancy is that the aging population constitutes a greater pro-
portion of patients undergoing medical treatments and presenting
for surgery.
Since the elderly are associated with a higher incidence of dis-
ease and concurrent use of medications, intraoperative manage-
ment of these patients can be challenging. For example, diabetes
and hypertension are highly prevalent in this population and are
known to impact various aspects of circulatory function. Med-
ications such as beta blockers and angiotensin converting enzyme
(ACE) inhibitors are commonly used in this age group, and the
resultant drug interactions may also compromise hemodynamic
stability and lead to untoward events. Even in the absence of these
complicating factors, elderly patients are intrinsically more sus-
ceptible to the circulatory effects of anesthetic agents and other
cardiovascular stressors due to the progressive structural and
functional changes in the circulation that invariably occur with
aging.
Due to increasing life expectancies in an ever-growing elderly
population, studies pertaining to the circulatory changes in these
patients are becoming increasingly timely and relevant. The focus
of the present review is to consolidate the available information
on aging as it pertains to vascular function and the intraopera-
tive maintenance of hemodynamic stability in the elderly patient.
Thus, rather than focusing on the mechanisms of aging that leads
to progressive deterioration of circulatory function over a long
period of time, we discuss aspects of the aging vasculature that are
more relevant in the acute regulationof bloodpressure – an impor-
tant aspect in the intraoperative setting. We subsequently discuss
the vascular effects of certain notable anesthetic agents, and where
evidence is available, discuss some of the mechanisms underlying
their effects. For more detailed reviews on the progressive vascular
changes that occur with aging, see the following references: Seals
et al. (2006), Mitchell (2008), Lekontseva et al. (2010), as well as
those included in this issue of Frontiers in Physiology.
HEMODYNAMIC INSTABILITY AND AGING
One of the greatest challenges in intraoperative care for elderly
patients is the maintenance of stable hemodynamic parameters.
In particular, prevention of hypotension resulting in reduced
end-organ perfusion is a primary concern. Elderly patients are
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more prone to developing hypotension in general (Johnson et al.,
1965; Caird et al., 1973; Lipsitz et al., 1983; Shannon et al., 1986),
but this may be exacerbated in surgery due to the fact that many
anesthetic agents are, by nature, hypotensive-inducing. Hypoper-
fusion may be particularly harmful in elderly patients for several
reasons. First, organs in elderly patients are accustomed to perfu-
sion at higher pressures (Hoffman et al., 1981;Harrison et al., 1988;
Tomanek, 1990); thus, in a patient with ischemic heart disease and
long-standing hypertension, a decrease in blood pressure intra-
operatively toward the “low-normal range” of healthy adults may
actually be detrimental. Second, due to an age-associated decline
in function, organs in the elderly appear more susceptible to loss
of perfusion (Corcoran and Hillyard, 2011).
Given the prevalence of hypertension in the elderly popula-
tion, it is perhaps counterintuitive that these patients are more
susceptible to intraoperative hypotension (Reich et al., 2005).
This hemodynamic “instability” stems from multiple factors act-
ing in concert. First, the circulation in elderly patients is highly
dependent on preload, such that alterations in vascular tone can
have a large inﬂuence on cardiac output and end-organ perfusion
(Corcoran and Hillyard, 2011). Second, evidence indicates that
“physiologic reserve”declines with age (Lipsitz, 2004). Physiologic
reserve broadly refers to a system’s capacity to copewith homeosta-
tic perturbations. In the context of acute bloodpressure regulation,
changes from the operating setpoint are buffered by two principal
mechanisms: (1) baroreceptor reﬂex, which modulates autonomic
nervous system activity; and (2) vascular responsiveness to shear
stress, which is coupled to endothelial nitric oxide (NO) pro-
duction (Park, 2002). Both baroreceptor capacity to buffer acute
blood pressure changes and shear stress-induced production of
NO are markedly attenuated in elderly patients (Mancia et al.,
1991), resulting in a diminished capacity to cope with alterations
in the blood pressure.
A third factor that contributes to the hemodynamic instability
in the elderly is the downregulation of vasodilatory mechanisms
(e.g.,NO,prostaglandins) and concomitant upregulationof vascu-
lar constrictor mechanisms [endothelin (ET)-1, sympathetic ner-
vous system (SNS) stimulation, renin–angiotensin system (RAS)
activity]. The sudden removal of these vasoconstrictor signal-
ing mechanisms by anesthetic agents (see below) may contribute
to profound and prolonged hypotension. A case in point is the
increased tonic SNS activity that occurs with aging (Seals and
Esler, 2000). The consequences of this increased SNS activity are
several-fold, but perhaps the most important implications are that
(1) there is a greater autonomic support of arterial pressure in
elderly patients compared to young patients (Jones et al., 2001),
and (2) there is reduced responsiveness of alpha and beta recep-
tors to further increases in catecholamine release (Mack, 2004),
which may implicate receptor downregulation and post-receptor
desensitization mechanisms (Xiao and Lakatta, 1992; Pilotti et al.,
2004). Iatrogenic removal of this sympathetic “overstimulation”
may therefore result in an exaggerated reduction in vascular tone,
due to the increased reliance of peripheral vascular resistance on
autonomic stimulation, thereby resulting in hypotension. More-
over, there is a compounding effect of reduced baroreceptor sensi-
tivity which results in reduced sympathetic discharge (McConnell
et al., 2009), coupledwith reduced peripheral tissue responsiveness
to released catecholamines (Ramos Macias et al., 1992; Sugiyama
et al., 1996;Davy et al., 1998;Dinenno et al., 2001). In all, the elderly
circulatory systemhas a signiﬁcantly reduced capacity to copewith
hemodynamic disturbances, particularly in the case when SNS
activity is reduced.
VASCULAR CHANGES ASSOCIATED WITH AGING AND
EFFECTS OF ANESTHESIA: SPECIFIC AGENTS
Anesthetics can inﬂuence hemodynamic stability directly by alter-
ing cardiac function,vascular reactivity,or affecting cardiovascular
reﬂexes (Mallow et al., 1976; Westenskow et al., 1978; Bennett and
Stanley, 1979; Waxman et al., 1980; Brismar et al., 1982; Fairﬁeld
et al., 1991). Because cardiac and vascular function are in many
ways compromised with aging, the circulatory effects of anesthet-
ics are exacerbated in the elderly (Tokics et al., 1985). Given the
emphasis of the present review, we focus on the vascular effects
of two primary classes of general anesthetics: inhalational and
intravenous. It is also noteworthy that due to changes in phar-
macokinetics, elderly patients tend to be more sensitive to the
neurological effects of anesthetic agents. Although not discussed
herein, it is possible that the circulatory effects of anesthetic agents
may also be exacerbated in the elderly due to greater distribution
to the brain, particularly if greater concentrations are achieved
in the vasoregulatory centers; for information on these aspects of
anesthetic agents in the aging population, see the following reviews
(Kalker et al., 1991; Shafer, 2000; Kruijt Spanjer et al., 2011).
INHALATIONAL ANESTHETICS
While many of the vascular effects of anesthetic agents have been
well-characterized in young patients and animals, relatively few
studies have been done in the elderly or in animal models of
aging. Inhalational anesthetic agents such as sevoﬂurane, isoﬂu-
rane, and desﬂurane are widely acknowledged to cause greater
hypotension in elderly patients than in young patients, albeit the
scientiﬁc studies supporting this observation are generally lack-
ing (Ebert, 2002). The principal cause of hypotension appears to
implicate a loss vascular tone and reduction in total peripheral
resistance (Lynch, 1986; Housmans and Murat, 1988; Pagel et al.,
1991, 1993; Kikura and Ikeda, 1993), although the speciﬁc mecha-
nisms are not clear. There is evidence that inhalational anesthetic
agents decrease SNS activity, resulting in reduced vascular tone
and diminished baroreceptor responsiveness in the wake of blood
pressureﬂuctuations (Seagard et al., 1984;Tanaka et al., 1996). This
is important because sudden decreases in SNS activity may cause
excessive and prolonged vasodilation in the elderly, as described
above. Yu et al. (2004) have also shown that inhalational anes-
thetics may decrease vascular tone through inhibition of the RAS,
which is known to be upregulated in aging (Baruch, 2004; Diz,
2008). Given that angiotensin II is a strong vasoconstrictor and
may lead to increased vascular tone, it is tempting to speculate
that the sudden withdrawal of this system may produce a pro-
found hypotension, analogous to the situation involving the SNS,
as described above. However, evidence that directly implicates the
RAS in this exaggerated hypotensive effect is presently lacking.
Inhalational anesthetics have also been shown to have direct
vasodilatory effects on the vasculature, which may be implicated
in the exaggerated effects in the elderly. In isolated vessels of several
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species, inhalational anesthetics mitigate the contractile responses
to potassium chloride or norepinephrine; this effect was observed
whether the endothelium was intact or not (Akata, 2007), suggest-
ing a direct effect on vascular smooth muscle. Indeed, studies have
shown that many such anesthetic agents inﬂuence calcium mobi-
lization and sensitization (Tsuneyoshi et al., 2003; Akata, 2007)
as well as potassium channel function (Tanaka et al., 2007) in
vascular smooth muscle cells, with corresponding changes in ves-
sel contractility. Given the importance of calcium channels and
potassium channels in vascular tone, direct actions on these tar-
gets could potentially inﬂuence vascular responses to anesthetics
in aging patients, although little information is available on the
age-related changes with ion channels in the vasculature. There is
evidence for diminished expression of large-conductance calcium-
activated potassium channels in aging in both rodents and humans
(Marijic et al., 2001; Toro et al., 2002), although their contribution
to the vascular effects of inhalational anesthetic agents in aging is
not currently known.
Inhalational anesthetics also have vasodilatory-promoting
effects on endothelial function. Isoﬂurane has been shown to
decrease ET-1 production (Boillot et al., 1995), which may have
a profound effect in the elderly population given the increased
ET-1 contribution to vascular tone with age (Stauffer et al., 2008;
Goel et al., 2010). Inhalational anesthetics could also cause exces-
sive vasodilation in the elderly via an antioxidant effect. While
these agents do not appear to have intrinsic antioxidant effects
per se, certain agents such as isoﬂurane and sevoﬂurane have
been shown to increase endogenous antioxidant enzyme activ-
ity (Yang et al., 2011; Crystal et al., 2012), which may have a
role in decreasing vascular tone. Indeed, in aging patients, a
progressive increase in reactive oxygen species production is a
well-deﬁned etiological mechanism of vascular dysfunction and
increased vasoconstriction (Herrera et al., 2010; Ungvari et al.,
2010).
Interestingly, in contrast to those aforementioned studies,
inhalational anesthetics have also been shown to increase vascular
responsiveness to norepinephrine and KCl in rat mesenteric arter-
ies, an effect that is entirely dependent on an intact endothelium
(Stone and Johns, 1989; Izumi et al., 2000, 2001; Yoshino et al.,
2005). Similarly, several groups have shown that these agents also
inhibit endothelial-dependent vasodilation (Muldoon et al., 1988;
Toda et al., 1992; Uggeri et al., 1992; Yoshida and Okabe, 1992;
Park et al., 1997). The mechanisms underlying this latter obser-
vation are not clear, although neither NO, endothelium-derived
hyperpolarizing factor, prostaglandin H synthase, and lipoxyge-
nase pathways, nor ET-1, angiotensin II, or serotonin receptors
appear to be implicated; calcium, potassium, and sodium chan-
nels are obvious potential targets. Taken together, these studies
demonstrate that anesthetic effects on the endothelium,are in part,
vasoconstrictor innature.Althoughpuzzling, this apparent dispar-
itymay be reconciled by the fact that the net effect of an agent is the
sumof all simultaneous effects on the vessel (Muldoon et al., 1988).
Therefore, while the endothelial effects of anesthetics appears to
be vasoconstrictor in nature, the net effect, taking into account the
effects of inhaled anesthetics on smooth muscle function, SNS,
RAS, and other local and humoral factors, is vasodilatory. Since
elderly patients are known to have altered endothelial secretory
proﬁles, it is tempting to speculate that the hypotensive effects
of inhalational anesthetics stem, at least in part, from mitigated
endothelial vasoconstrictor effects producing an overall enhanced
vasodilation. Studies are needed to directly test this hypothesis.
INTRAVENOUS ANESTHETICS
Etomidate
In vessels from young rats, etomidate causes direct vasodila-
tion ex vivo (Bazin et al., 1998), involving increased vasodilator
prostaglandins (Asher et al., 1992) and decreased ET-1 production
(Hayashi et al., 1999). However, in vivo, administration of etomi-
date has little effect on blood pressure in young patients; in fact,
its hemodynamic stability during induction of general anesthesia
make it a preferred agent in many clinical scenarios (Gooding and
Corssen, 1977; Criado et al., 1980). The hemodynamic stability of
etomidate appears to stem from a lack of inhibition of SNS func-
tion (Ebert et al., 1992; Robinson et al., 1997). Thus, despite caus-
ing direct vasodilation, hemodynamic perturbations are transient
and easily corrected by baroreceptor stimulation of heart rate and
contractility. However, when administered to elderly patients, eto-
midate causes a 20–30% decrease in blood pressure (Larsen et al.,
1988). This hypotensive effect is not well understood, although
recent studies have provided insights into its mechanism. The
reason may be due in part to the interaction between etomidate
and adrenoceptor signaling. Etomidate enhances norepinephrine-
induced constriction in mesenteric resistance arteries in young
rats, resulting in increased vascular tone; this effect appears to be
lost in aged rats (Shirozu et al., 2009). The authors of this study
suggested that hypotension with etomidate in aged patients is not
due to direct actions on the vasculature but rather due to interfer-
encewithnorepinephrine-induced vasoconstriction. Interestingly,
Ebert et al. (1992) demonstrated that etomidate does not reduce
overall release of catecholamines from sympathetic nerve termi-
nals, suggesting that the majority of the blood pressure-lowering
effects in the elderly may stem from altering the adrenoceptor
responsiveness to catecholamines. Thus, despite increased NE lev-
els in aging patients, etomidate-induced decrease in adrenoceptor
responsiveness results in a more profound vasodilatory effect.
Etomidate is also known to cause adrenocortical suppression
(Allolio et al., 1985; Lamberts et al., 1987), resulting in diminished
cortisol release which can be problematic in certain patients (e.g.,
septic patients). Cortisol increases blood pressure principally by
increasing sensitivity of the vasculature to catecholamines. Thus,
etomidate-induced reduction in cortisol production may also play
a role in causing hypotension in the intraoperative period, again
making elderly patients more susceptible to this effect due to the
progressive loss of catecholamine responsiveness with aging. This
is supported by a recent case report of an elderly patient given a
single dose of etomidate causing refractory hypotension that was
only reversible with cortisol administration (Lundy et al., 2007).
It is noteworthy that this mechanism is likely in addition to that
described by Shirozu et al. (2009) since those experiments were
done in isolated vessels.
Propofol
It was recently reported that the use of propofol over other general
anesthetics, aswell as age of the patient, are independent predictors
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of clinically signiﬁcant hypotension inpatients undergoing general
anesthesia (Reich et al., 2005). The majority of hypotensive effects
of propofol appear to occur via reduced systemic vascular resis-
tance. Part of this effect may stem from the fact that propofol, in
contrast to etomidate, diminishes SNS function (Robinson et al.,
1997), which may result in vasodilation. Moreover, loss of SNS
activity results in decreased compensatory heart rate and contrac-
tility in the wake of hypotension,may be an important contributor
to its hypotensive effects in the elderly, as described above. Propofol
has also been shown to cause direct relaxation in several vascular
beds, [e.g., aorta in rat (Boillot et al., 1999), coronary artery in
the pig (Park et al., 1995), and mesenteric arteries in humans and
rats (Moreno et al., 1997; Yamazaki et al., 2002)], although studies
by Yamashita et al. (1999) and Kamitani et al. (1995) have shown
opposite effects in rabbits , which may suggest species differences.
In young animals, propofol increases NO production in isolated
endothelial cells concomitant with decreased ET-1 release from
the endothelium (Cheng et al., 2009). Tanabe et al. (1998) also
showed that propofol inhibits ET-1 signaling in vascular smooth
muscle. Given the role of diminished NO and increased ET-1 as
important mechanisms in vascular aging, it seems plausible that
these mediators may be implicated in the exaggerated hypotensive
effects in elderly patients.
In our studies, we demonstrated that propofol causes enhanced
mesenteric artery relaxation in aged rats when compared to young,
and this effect was attributed to increasedNObioavailability (Gra-
gasin and Davidge, 2009). We also demonstrated that the combi-
nation of antioxidant enzymes superoxide dismutase and catalase
enhance vasodilation to acetylcholine similar to propofol in aged
rats (Gragasin and Davidge, 2009). On the basis of these stud-
ies, we suggested that propofol may exert part of its vasodilatory
effects via intrinsic antioxidant effects (Ansley et al., 1998), since it
is structurally similar to α-tocopherol (vitamin E). Thus, we spec-
ulate that the vasodilatory effectmay bemore pronounced because
aging vessels have increased oxidative stress. These data may also
suggest that the use of NOdonors to treat acute hypertensive crises
intraoperatively may be harmful in elderly patients anesthetized
with propofol. Indeed, it is already known that elderly patients
have an increased sensitivity to nitroglycerin causing hypotension
(Cahalan et al., 1992), and the presence of propofol may cause an
unwanted synergistic blood pressure-lowering effect.
More recently, we investigated the effects of propofol in aged
animals treated with the ACE inhibitor captopril. ACE inhibitors
are commonly prescribed medications for blood pressure control
in elderly patients, and it is well documented that these treated
patients exhibit greater hypotension under general anesthesia
(Bertrand et al., 2001; Comfere et al., 2005; Kheterpal et al., 2008).
It has been suggested that there may be an interaction between
ACE inhibitors and propofol which causes severe hypotension
(Malinowska-Zaprzalka et al., 2005). In an aging rodent model,
chronic treatment with captopril increases endothelial-dependent
vasodilation in the presence of propofol (unpublished data). Inter-
estingly, NO was not responsible for the differential response
observed between control and captopril-treated rats (unpub-
lished data); thus there may be alterations in other vasodilating
mechanisms such as endothelial-derived hyperpolarizing factor
(Hutri-Kahonen et al., 1997; Goto et al., 2000). The caveat is that
isolated vessels may not recapitulate in vivo vascular responses,
and therefore further investigation using integrated,whole-animal
approaches are needed to identify the mechanisms underlying this
enhanced relaxation.
CONCLUSION
Aging is associated with a multitude of changes at the vascu-
lar level, including structural changes, enhanced oxidative stress,
and altered secretory proﬁles of vasoconstrictor and vasodila-
tors. Anesthetic agents may acutely alter this balance leading
to excessive and unwanted vasodilation in the elderly, and elu-
cidating the underlying mechanisms dictating vascular func-
tion and its changes with age are therefore crucial. Moreover,
given that elderly patients often have existing co-morbidities,
additional studies are needed to elucidate the mechanisms of
anesthetic-induced changes in hemodynamics in the presence
of overt disease, such as hypertension, diabetes, chronic kid-
ney disease, or more surreptitious conditions associated with
aging, such as nutritional deﬁciencies (e.g., iron deﬁciency),
which may have additional effects on vascular function. From a
clinical perspective, the Anesthesiologist is tasked with making
important decisions about drug use in elderly patients, consid-
ering factors such as patient safety, neurological recovery, and
drug availability. Gaining further knowledge of the mechanisms
of action of anesthetic agents at the vascular level as well in
intact animal models can potentially be translated to the bed-
side, possibly changing clinical practice by enhancing manage-
ment of circulatory health in the elderly during the intraoperative
period.
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